The HRA2pl fusion peptide exerts in vitro antiviral activity against human respiratory paramyxoviruses and pneumoviruses

The HRA2pl fusion peptide exerts in vitro antiviral activity against human respiratory paramyxoviruses and pneumoviruses

Acute respiratory infections are a group of diseases caused by viruses, bacteria, and parasites that mainly affect children until the age of 5 and immunocompromised senior adults. In Mexico, these infections are the main cause of morbidity in children, with more than 26 million cases of respiratory...

Full description

Bibliographic Details
Main Authors: Uriel Cruz Meza, Norvell Perezbusta Lara, Laura Chávez Gómez, Marcela Solís Rodríguez, Javier R. Ambrosio Hernández, Rocio Tirado Mendoza
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
acute respiratory infections
human respiratory virus
paramyxovirus
pneumovirus
fusion peptide
syncytium size
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2023.1125135/full

Internet

https://www.frontiersin.org/articles/10.3389/fcimb.2023.1125135/full

Similar Items